Health Products

Advia Centaur Systems - HIV Ag/Ab Combo (CHIV) Assays (2013-09-17)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
More than 10 numbers, contact manufacturerB.    Advia Centaur XP - HIV Ag/Ab Combo (CHIV) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave.
Tarrytown
10591
New York
UNITED STATES
06520528
More than 10 numbers, contact manufacturerC.    Advia Centaur CP - HIV Ag/Ab Combo (CHIV) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave.
Tarrytown
10591
New York
UNITED STATES
06520528
More than 10 numbers, contact manufacturerA.    Advia Centaur System - HIV Ag/Ab Combo (CHIV) Assays
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave.
Tarrytown
10591
New York
UNITED STATES
06520528

Introduction

Recalled products
  1. Advia Centaur System - HIV Ag/Ab Combo (CHIV) Assays
  2. Advia Centaur XP - HIV Ag/Ab Combo (CHIV) Assay
  3. Advia Centaur CP - HIV Ag/Ab Combo (CHIV) Assay

Reason

The analytical sensitivity statements in the Advia Centaur / XP and Advia Centaur CP IFUs were based on one lot of reagent. Siemens evaluated the current P24 analytical sensitivity with multiple lots to determine if the HIV Ag / Ab combo (CHIV) assay is meeting the IFU statements. Five out of the seven lots evaluated on the Advia Centaur / XP and four out of seven lots evaluated on the Advia Centaur CP did not meet the statement in the IFU with regard to P24 analytical sensitivity. However, the CHIV assay is meeting the design requirements (Dir target < 1.5 IU/mL, Dir minimum < 2.0 IU/ml) and the CTS analytical sensitivity requirement of less than and equal to  2.0 IU/mL.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime